Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 10Gynecologic 7Gastrointestinal 6Thoracic 5Other hematologic neoplasm 3Head & Neck 3CNS 3Genitourinary 2Sarcoma 1Myeloid 1Lymphoid 1Dermatologic 1Classical hematology 1

Conditions

Sarcoma 436Osteosarcoma 132Sarcoma, Ewing 89Melanoma 80Rhabdomyosarcoma 77Neoplasms 71Gastrointestinal Stromal Tumors 63Neuroblastoma 62Bone Neoplasms 62Breast Neoplasms 61Ovarian Neoplasms 60Colorectal Neoplasms 60Glioblastoma 55Neoplasm Metastasis 52Liposarcoma 52Dendritic Cell Sarcoma, Interdigitating 45Carcinoma, Non-Small-Cell Lung 43Leiomyosarcoma 42Gliosarcoma 42Stomach Neoplasms 41Pancreatic Neoplasms 41Lymphoma 36Uterine Cervical Neoplasms 35Sarcoma, Synovial 35Carcinoma, Renal Cell 35Rhabdoid Tumor 34Neurofibrosarcoma 34Lung Neoplasms 34Glioma 34Sarcoma, Kaposi 33

Interventions

liposomal doxorubicin 1Taxes 1Paclitaxel 1Lomustine 1Irinotecan 1Gemcitabine 1Doxorubicin 1Carboplatin 1Albumin-Bound Paclitaxel 13-(5-fluorobenzofuran-3-yl)-4-(5-methyl-5H-(1,3)dioxolo(4,5-f)indol-7-yl)-pyrrole-2,5-dione 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Hereditary Sensory and Autonomic Neuropathies × Sarcoma × 1 year × Clear all
NCT03678883 2026-04-03

9-ING-41 in Patients With Advanced Cancers

Actuate Therapeutics Inc.

Phase 2 Active not recruiting
350 enrolled
BreastCNSGastrointestinalGenitourinaryLymphoidOther hematologic neoplasmSarcomaThoracic

Bone Neoplasms, Breast Neoplasms, Glioma, Kidney Neoplasms, Lung Neoplasms, Lymphoma, Non-Hodgkin, Neoplasm Metastasis, Neoplasms, Hereditary Sensory and Autonomic Neuropathies, Pancreatic Neoplasms, Sarcoma, Colorectal Neoplasms, Leukemia-Lymphoma, Adult T-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡